Preimplantation Genetic Testing Prevented Intergenerational Transmission of X-Linked Alport Syndrome

• Published in: Kidney diseases (Basel, Switzerland) Vol. 7; no. 6; pp. 514 - 520
• Main Authors: Hu, Xiaoling, Zhang, Jiahui, Lv, Yuan, Chen, Xijing, Feng, Guofang, Wang, Liya, Ye, Yinghui, Jin, Fan, Zhu, Yimin
• Format: Report
• Language: English
• Published: 01.11.2021
• DOI: 10.1159/000517796
• ISSN: 2296-9381

BACKGROUNDAlport syndrome (AS) is a hereditary renal basement membrane disease that can lead to end-stage renal disease in young adults. It can be diagnosed by genetic analysis, being mostly caused by mutations in COL4A3, COL-4A4, and COL4A5. To date, there is no radical cure for this disease. OBJECTIVESThe aim of this study was to avoid the transmission of AS within an affected family by selecting healthy embryos for uterine transfer. The embryos were identified by preimplantation genetic testing for monogenic disorders (PGT-M). METHODSWe used next-generation sequencing (NGS) to identify mutations in the proband and his parents. The results of NGS were confirmed by Sanger sequencing. Targeted NGS combined with targeted single-nucleotide polymorphism haplotyping was used for the in vitro identification of COL4A5 mutations in human embryos to prevent their intergenerational transmission. RESULTSThe c.349_359delGGACCTCAAGG and c.360_361insTGC mutations in COL4A5 were identified in a family affected by X-linked AS. Whole-genome sequencing by NGS with targeted haplotyping was performed on biopsied trophectoderm cells. A healthy baby was born after transfer of a single freeze-thawed blastocyst. CONCLUSIONSThe use of targeted NGS for identifying diagnostic markers combined with targeted haplotyping is an easy and efficient PGT-M method for preventing intergenerational transmission of AS.